Seegene Unveils New STARlet-AIOS All-in-One Solution for All Molecular Testing at AACC 2021
By LabMedica International staff writers Posted on 29 Sep 2021 |
Seegene, Inc. (Seoul, Korea) unveiled its new STARlet-AIOS All-in-One Solution for All Molecular Testing at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo held at the Georgia World Congress Center in Atlanta, September 26-30.
Over the span of the four day event, attendees connected with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.
At AACC 2021, Seegene introduced its new STARlet-AIOS which is a unique modular configuration that integrates existing standalone instruments, enabling easy installation, upgrade and maintenance. Combined with Seegene's proprietary high-multiplex real-time PCR reagent technology, Seegene STARlet-AIOS provides an ultimate solution that could perform various syndromic tests with one system. The STARlet-AIOS is the world's one and only modular concept that enables a fully automated workflow while maintaining the standalone instruments, STARlet and CFX96 Dx. It no longer requires a large installation space and provides convenience in maintenance and repair.
What sets Seegene STARlet-AIOS apart is its unique high multiplex Real-Time PCR reagent technology. Within the same disease group such as respiratory, GI, or STI, Seegene’s syndromic test can find the exact cause of a specific symptom with a single test. Seegene’s currently available products can be applied on the STARlet-AIOS and its newly developed products will also be compatible with the solution, thus further increasing its expandability. With the all-in-one solution, diverse syndromic tests can be carried out with a single system, optimizing the testing environment.
From sample input to data analysis, Seegene STARlet-AIOS provides a streamlined process for molecular testing. The entire workflow is fully automated with Seegene’s solution. Just a click of a button is all that is needed. An inserted sample plate goes through the extraction, followed by the PCR setup process within the extraction instrument STARlet. Once the extraction and PCR setup are finished, the sample plate is moved down to the lower level by the elevator robot. The plate is then picked up by the plate handler robot and moved to the plate sealer for automated sealing process. Once the sealing is done, the plate is again picked up by the plate handler robot and put into the CFX96 for Real-Time PCR. After the PCR, Seegene’s seamless software solution provides not only accurate quantitative test results but also customized statistical analysis in an easy to see visualized format with insights.
By completely eliminating the manual process, the possibility of human error and contamination is minimized throughout the entire testing process. As a result, the medical staff can obtain accurate test results by working in a safe and efficient environment. Seegene STARlet-AIOS is a compact yet complete testing solution that generates same-day results even with small sample sizes, making it perfect for clinics and labs of all sizes.
Related Links:
Seegene, Inc.
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans